These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18705145)

  • 41. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
    Strony J; Hoffman R; Hanson M; Veltri E
    Clin Ther; 2008 Dec; 30(12):2280-97. PubMed ID: 19167588
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sugar-substituted 2-azetidinones as cholesterol absorption inhibitors.
    Vaccaro WD; Sher R; Davis HR
    Bioorg Med Chem Lett; 1998 Jan; 8(1):35-40. PubMed ID: 9871624
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Time- and dose-dependent effect of psyllium on serum lipids in mild-to-moderate hypercholesterolemia: a meta-analysis of controlled clinical trials.
    Wei ZH; Wang H; Chen XY; Wang BS; Rong ZX; Wang BS; Su BH; Chen HZ
    Eur J Clin Nutr; 2009 Jul; 63(7):821-7. PubMed ID: 18985059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Uncertainty dogs Zetia and Vytorin.
    Harv Heart Lett; 2008 Nov; 19(3):7. PubMed ID: 19031588
    [No Abstract]   [Full Text] [Related]  

  • 45. [High dosage stain protects heart and brain from recurrence].
    MMW Fortschr Med; 2008 Nov; 150(48):118-9. PubMed ID: 19125516
    [No Abstract]   [Full Text] [Related]  

  • 46. HDL: still a target for new therapies?
    Nicholls SJ
    Curr Opin Investig Drugs; 2008 Sep; 9(9):950-6. PubMed ID: 18729001
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of cholesteryl ester transfer protein inhibitor on vitamin E transport should be studied.
    Masterjohn C
    Am Heart J; 2009 Jul; 158(1):e11; author reply e13. PubMed ID: 19540377
    [No Abstract]   [Full Text] [Related]  

  • 48. Letter by Westerink and Visseren regarding article, "Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation".
    Westerink J; Visseren FL
    Circulation; 2009 Sep; 120(9):e66; author reply e69-70. PubMed ID: 19720942
    [No Abstract]   [Full Text] [Related]  

  • 49. Letter by Settergren et al regarding article, "Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation".
    Settergren M; Rydén L; Pernow J
    Circulation; 2009 Sep; 120(9):e68; author reply e69-70. PubMed ID: 19720944
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect on serum lipid levels of switching dose of ezetimibe from 10 to 5 mg.
    Baruch L; Agarwal S; Gupta B; Haynos A; Eng C
    Am J Cardiol; 2009 Jun; 103(11):1568-71. PubMed ID: 19463517
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Letter by Tershakovec et al regarding article, "Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation".
    Tershakovec AM; Veltri EP; Pasternak RC
    Circulation; 2009 Sep; 120(9):e67; author reply e69-70. PubMed ID: 19720943
    [No Abstract]   [Full Text] [Related]  

  • 52. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
    Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
    Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
    [No Abstract]   [Full Text] [Related]  

  • 53. Hydroxypropylmethylcellulose lowers cholesterol in statin-treated men and women with primary hypercholesterolemia.
    Maki KC; Carson ML; Miller MP; Anderson WH; Turowski M; Reeves MS; Kaden V; Dicklin MR
    Eur J Clin Nutr; 2009 Aug; 63(8):1001-7. PubMed ID: 19209184
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia.
    Masuda D; Nakagawa-Toyama Y; Nakatani K; Inagaki M; Tsubakio-Yamamoto K; Sandoval JC; Ohama T; Nishida M; Ishigami M; Yamashita S
    Eur J Clin Invest; 2009 Aug; 39(8):689-98. PubMed ID: 19490064
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of rutin on lipid profile in hypercholesterolaemic rats.
    Ziaee A; Zamansoltani F; Nassiri-Asl M; Abbasi E
    Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):253-8. PubMed ID: 19175365
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Colesevelam hydrochloride: usefulness of a specifically engineered bile acid sequestrant for lowering LDL-cholesterol.
    Corsini A; Windler E; Farnier M
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):1-9. PubMed ID: 19237992
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The development of novel anti-hyperlipidemic drugs: a tough business gets tougher.
    Krause BR
    Curr Opin Investig Drugs; 2008 Sep; 9(9):945-9. PubMed ID: 18729000
    [No Abstract]   [Full Text] [Related]  

  • 58. Evidence mandating earlier and more aggressive treatment of hypercholesterolemia.
    Steinberg D; Glass CK; Witztum JL
    Circulation; 2008 Aug; 118(6):672-7. PubMed ID: 18678783
    [No Abstract]   [Full Text] [Related]  

  • 59. Role of ezetimibe in the management of patients with atherosclerosis.
    Hamilton P
    Coron Artery Dis; 2009 Mar; 20(2):169-74. PubMed ID: 19106797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
    Hou R; Goldberg AC
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.